News Image

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

Provided By GlobeNewswire

Last update: Mar 20, 2025

MALVERN, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the fourth quarter and full year ended December 31, 2024.

Read more at globenewswire.com

TELA BIO INC

NASDAQ:TELA (7/23/2025, 4:30:01 PM)

After market: 2.08 +0.14 (+7.22%)

1.94

+0.03 (+1.57%)



Find more stocks in the Stock Screener

Follow ChartMill for more